These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Diagnosis
380 results:

  • 1. Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants.
    Chen S; Gu J; Wu K; Zhao X; Lu Y
    Cancer Biol Med; 2024 Jun; 21(6):473-83. PubMed ID: 38940668
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Are sporadic colorectal cancers in young patients distinct from those in elderly patients?
    Yang IJ; Kim DW; Lee J; Ahn HM; Oh HK; Kang SB; Suh JW; Kim MH; Oh HJ; Kim HK; Kim MJ; Park JW; Ryoo SB; Park KJ; Jeong SY; Oh JH
    Colorectal Dis; 2024 Jul; 26(7):1405-1414. PubMed ID: 38881232
    [TBL] [Abstract] [Full Text] [Related]  

  • 3.
    El Zaitouni S; Laraqui A; Ghaouti M; Benzekri A; Kettani F; Bajjou T; Sekhsokh Y; Benmokhtar S; Jafari M; Baba W; Oukabli M; El Annaz H; Abi R; Tagajdid MR; El Kochri S; Lahlou IA; Ameziane El Hassani R; Ennibi K
    Cancer Control; 2024; 31():10732748241262179. PubMed ID: 38875469
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical Outcomes in Patients With Krukenberg Tumors From colorectal cancer.
    Ostowari A; Hasjim BJ; Lim L; Yu J; Nguyen L; Dayyani F; Zell J; Cho M; Senthil M; Eng OS
    J Surg Res; 2024 Jul; 299():343-352. PubMed ID: 38795557
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Temporal trends and regional variability in braf and KRAS genetic testing in Denmark (2010-2022): Implications for precision medicine.
    Frost MG; Jensen KJ; Jimenez-Solem E; Qvortrup C; Kuhlmann TP; Andersen JL; Høgdall E; Petersen TS
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23236. PubMed ID: 38656617
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological characteristics of Lynch-like syndrome.
    Nakamori S; Takao M; Takao A; Natsume S; Iijima T; Kojika E; Nakano D; Kawai K; Inokuchi T; Fujimoto A; Urushibara M; Horiguchi SI; Ishida H; Yamaguchi T
    Int J Clin Oncol; 2024 Jul; 29(7):944-952. PubMed ID: 38642190
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 8. Sporadic deficient mismatch repair in colorectal cancer increases the risk for non-colorectal malignancy: A European multicenter cohort study.
    Gkekas I; Jan N; Kaprio T; Beilmann-Lehtonen I; Fabian P; Tavelin B; Böckelman C; Edin S; Strigård K; Svoboda T; Hagström J; Barsova L; Jirasek T; Haglund C; Palmqvist R; Gunnarsson U
    J Surg Oncol; 2024 Jun; 129(7):1295-1304. PubMed ID: 38470492
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
    Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
    Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.
    Hammarström K; Nunes L; Mathot L; Mezheyeuski A; Lundin E; Korsavidou Hult N; Imam I; Osterlund E; Sjöblom T; Glimelius B
    Int J Cancer; 2024 Jul; 155(1):40-53. PubMed ID: 38376070
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical features and mutation analysis of class 1/2/3 braf mutation colorectal cancer.
    Huang Y; Jia W; Zhao G; Zhao Y; Zhang S; Li Z; Wu G
    Chin Clin Oncol; 2024 Feb; 13(1):3. PubMed ID: 38372057
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur).
    Hitchcock KE; Miller ED; Shi Q; Dixon JG; Gholami S; White SB; Wu C; Goulet CC; George M; Jee KW; Wright CL; Yaeger R; Shergill A; Hong TS; George TJ; O'Reilly EM; Meyerhardt JA; Romesser PB
    BMC Cancer; 2024 Feb; 24(1):201. PubMed ID: 38350888
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Exploring the role of sporadic braf and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
    Tang J; Lam GT; Brooks RD; Miles M; Useckaite Z; Johnson IR; Ung BS; Martini C; Karageorgos L; Hickey SM; Selemidis S; Hopkins AM; Rowland A; Vather R; O'Leary JJ; Brooks DA; Caruso MC; Logan JM
    Cancer Lett; 2024 Mar; 585():216639. PubMed ID: 38290660
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. United States-Based colorectal cancer Surgical Trials Lack Representation and Adequate Reporting of Racially and Ethnically Diverse Participants: Systematic Review and Regression Analysis.
    Ore AS; Areán-Sanz R; Liu BS; Arndt KR; Hernandez Alvarez A; Ponce CJ; Bain PA; Messaris E
    Dis Colon Rectum; 2024 May; 67(5):624-633. PubMed ID: 38276952
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in
    Tsai HL; Huang CW; Chen YC; Su WC; Chang TK; Chen PJ; Li CC; Chang YT; Wang JY
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138211
    [No Abstract]    [Full Text] [Related]  

  • 16. High-Fidelity Identification of Single Nucleotide Polymorphism by Type V CRISPR Systems.
    He Y; Shao S; Chen J
    ACS Sens; 2023 Dec; 8(12):4478-4483. PubMed ID: 38010835
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Serrated colorectal cancer: preclinical models and molecular pathways.
    Aiderus A; Barker N; Tergaonkar V
    Trends Cancer; 2024 Jan; 10(1):76-91. PubMed ID: 37880007
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An incidental traditional serrated adenoma of the gallbladder: A case report.
    Abecia Martínez EI; Ríos Ballestín G; Castillo Malla J; Martínez Arnau N; Hörndler Argarate C
    Rev Esp Patol; 2023; 56(4):271-274. PubMed ID: 37879824
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Development and adaptations of the Graded Prognostic Assessment (GPA) scale: a systematic review.
    Ribeiro LM; Bomtempo FF; Rocha RB; Telles JPM; Neto EB; Figueiredo EG
    Clin Exp Metastasis; 2023 Dec; 40(6):445-463. PubMed ID: 37819546
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. EARLY-ONSET colorectal cancer: AN ELEVEN-YEAR ANALYSIS OF CLINICOPATHOLOGICAL CHARACTERISTICS AT A TERTIARY HEALTHCARE CENTER.
    Piñerúa-Gonsálvez JF; Zambrano-Infantino RDC; Rizzo-Rodríguez MA; Dueñas-Diez A; Fernández-Salazar L
    Arq Gastroenterol; 2023; 60(3):315-321. PubMed ID: 37792760
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 19.